Skip to main navigation
Ascendis Pharma Logo
  • Overview
  • Events & Presentations
  • News Releases
    • For Global Media Only
    • For U.S. Media Only
  • Corporate Governance
    • Corporate Governance Documents & Charters
    • Leadership
    • Committee Composition
  • Stock
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
  • Financial & Filings
    • Quarterly Reports
    • SEC Filings
    • Annual General Meeting
    • Extraordinary General Meeting
      • Sept. 9, 2022 EGM
      • Nov. 18, 2021 EGM

Events & Presentations

Events & Presentations

Upcoming Events

More events are coming soon.

Past Events

March 15, 2023 at 12:00 PM EDT
Oppenheimer 33rd Annual Healthcare Conference
Click here for webcast

Presentations

January 8, 2023
41st Annual J.P. Morgan Healthcare Conference Presentation
November 13, 2022
TransCon™ CNP ACcomplisH Trial Topline Results
November 11, 2022
TransCon™ TLR7/8 Agonist Initial Results from Dose Escalation Portion of transcendIT-101 Trial
September 12, 2022
TransCon™ PTH Week 110 Phase 2 PaTH Forward Trial Presentation
March 13, 2022
Phase 3 PaTHway Trial top-line results
January 10, 2022
40th Annual J.P. Morgan Healthcare Conference Presentation
December 14, 2021
Virtual R&D Program Update
November 30, 2021
Investor Presentation
November 18, 2021
TransCon PTH PaTH Forward Trial Week 84 Top-Line Results
August 25, 2021
SKYTROFA® FDA Approval Slide Presentation

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »

Shareholder Tools

RSS Feeds
Email Alerts
IR Contact

Footer Corporate Menu

  • TransCon
  • About us
  • Pipeline
  • Patients
  • Investors & News
  • Contact Us

Footer Copyrights Menu

  • Privacy Policy
  • Terms of Use
Ascendis, Ascendis Pharma, Ascendis Pharma logo, the company logo and TransCon are trademarks owned by the Ascendis Pharma group
© March 2023 Ascendis Pharma